These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7579851)

  • 41. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
    [No Abstract]   [Full Text] [Related]  

  • 42. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combination therapy of beta blockers for heart failure].
    Watanabe M; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
    [No Abstract]   [Full Text] [Related]  

  • 45. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
    Bollano E; Täng MS; Hjalmarson A; Waagstein F; Andersson B
    Heart; 2003 Jun; 89(6):621-4. PubMed ID: 12748215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E; Levy P
    Pharmacoeconomics; 2002; 20(14):963-77. PubMed ID: 12403637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on pharmacological advances.
    Fonarow G
    J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
    [No Abstract]   [Full Text] [Related]  

  • 51. Management of advanced heart failure.
    Van Bakel AB; Chidsey G
    Clin Cornerstone; 2000; 3(2):25-35. PubMed ID: 11205722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug therapy of cardiac insufficiency: status 1995].
    Rickenbacher P; Buser P; Osswald S; Pfisterer M
    Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties].
    Komajda M
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1205-7. PubMed ID: 9488765
    [No Abstract]   [Full Text] [Related]  

  • 55. Treating patients with Chagas' cardiomyopathy with chronic heart failure in the contemporary era.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A
    Am Heart J; 2007 Nov; 154(5):e35; author reply e33. PubMed ID: 17967576
    [No Abstract]   [Full Text] [Related]  

  • 56. Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
    Fedorov VN; Sal'nikov EV; Sidorov AV; Bogatushin AV; Fateev MM
    Bull Exp Biol Med; 2006 Jan; 141(1):40-3. PubMed ID: 16929960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementing clinical trial results into clinical practice for patients with heart failure.
    Kim TC; Rodeheffer RJ; Kopecky SL
    Am J Cardiol; 2003 Mar; 91(5):581-2. PubMed ID: 12615264
    [No Abstract]   [Full Text] [Related]  

  • 58. Case 4: A patient with systemic hypertension and congestive heart failure.
    Kloner RA; Friedewald VE
    Am J Cardiol; 2000 Apr; 85(7):917-8, A10. PubMed ID: 10758944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical trials on heart failure].
    Cosín Aguilar J; Hernándiz Martínez A
    Rev Esp Cardiol; 2001; 54 Suppl 1():22-31. PubMed ID: 11535185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Drug treatment of chronic heart failure].
    Böhm M; Werner N; Kindermann M
    Clin Res Cardiol; 2006; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.